The InflamaCORE team, the University of Miami and ZyVersa Therapeutics receive a grant from the Michael J. Fox Foundation to study the therapeutic benefits of IC100 in Parkinson's Disease.
InflamaCORE, LLC and the University of Miami obtain a fast track STTR grant from the NIH to develop IC100 for the treatment of spinal cord injury related inflammation
InflamaCORE team obtains funds from the University of Miami to humanize a monoclonal antibody against the human ASC protein.
The InflamaCORE team and the University of Miami signs a sponsored research aggreement with ZyVersa Therapeutics, Inc to study the inflammasome in renal and metabolic diseases .